Forecast the Statement of Cash Flows Refer to the Medtronic PLC financial statement below. Use the information to forecast Medtronic's FY2017 statement of cash flows.

Medtronic plc
Consolidated Statements of Income
12 Months Ended ($ millions)		2017 EST.	Apr. 29, 2016
Net sales		$35,531	$28,833
Costs and expenses
Cost of products sold		11,151	9,142
Research and development expense		2,709	2,224
Selling, general, and administrative expense		11,538	9,469
Special charges (gains), net		-	70
Restructuring charges, net		218	290
Certain litigation charges, net		-	26
Acquisition-related items		352	283
Amortization of intangible assets		1,931	1,931
Other expense, net		107	107
Operating profit		7,525	5,291
Interest expense, net		955	955
Income from operations before income taxes		6,570	4,336
Provision for income taxes		1,314	798
Net income		$5,256	$3,538

Medtronic plc
Consolidated Balance Sheets
($ millions)		2017 EST.	Apr. 29, 2016
Current assets
Cash and cash equivalents		$5,663	$2,876
Investments		9,758	9,758
Accounts receivable		6,798	5,562
Inventories		4,230	3,473
Tax assets		844	697
Prepaid expenses and other current assets		1,513	1,234
Total current assets		28,806	23,600
Property, plant, and equipment, net		5,205	4,841
Goodwill		41,500	41,500
Other intangible assets, net		24,968	26,899
Long-term tax assets		1,697	1,383
Other assets		1,900	1,559
Total assets		$104,076	$99,782
Current liabilities
Short-term borrowing		6,176	993
Accounts payable		2,066	1,709
Accrued compensation		2,075	1,712
Accrued income taxes		695	566
Other accrued expenses		2,673	2,185
Total current liabilities		13,685	7,165
Long-term debt		24,071	30,247
Long-term accrued compensation & retirement benefits		1,759	1,759
Long-term accrued income taxes		3,562	2,903
Long-term deferred tax liabilities		4,538	3,729
Other long-term liabilities		2,322	1,916
Total liabilities		49,937	47,719
Shareholders' equity
Ordinary shares		-	-
Retained earnings		56,007	53,931
Accumulated other comprehensive (loss)		(1,868)	(1,868)
Total shareholders' equity		54,139	52,063
Total liabilities and stockholders' equity		$104,076	$99,782

Additional information

CAPEX/Net sales	3.6%
Depreciation expense/Prior year PPE, net	18.9%
Dividend payout ratio	60.5%

Use a negative sign with you answer to indicate a decrease in cash.

Medtronic plc
Forecasted Statement of Cash Flows ($ millions)
	2016 Est.
Net income	$Answer Incorrect 0.00 points out of 1.00
Depreciation	Answer Incorrect 0.00 points out of 1.00
Amortization	Answer Incorrect 0.00 points out of 1.00
Accounts receivable	Answer Incorrect 0.00 points out of 1.00
Inventories	Answer Incorrect 0.00 points out of 1.00
Tax assets	Answer Incorrect 0.00 points out of 1.00
Prepaid expense & other current assets	Answer Incorrect 0.00 points out of 1.00
Long-term tax assets	Answer Incorrect 0.00 points out of 1.00
Other assets	Answer Incorrect 0.00 points out of 1.00
Accounts payable	Answer Incorrect 0.00 points out of 1.00
Accrued compensation	Answer Incorrect 0.00 points out of 1.00
Accrued income taxes	Answer Incorrect 0.00 points out of 1.00
Other accrued expenses	Answer Incorrect 0.00 points out of 1.00
Long-term accrued income taxes	Answer Incorrect 0.00 points out of 1.00
Long-term deferred tax liabilities	Answer Incorrect 0.00 points out of 1.00
Other long-term liabilities	Answer Incorrect 0.00 points out of 1.00
Cash from operating activites	Answer Incorrect 0.00 points out of 1.00
CAPEX	Answer Incorrect 0.00 points out of 1.00
Cash from investing activites	Answer Incorrect 0.00 points out of 1.00
Dividends	Answer Incorrect 0.00 points out of 1.00
Current maturities of L-T debt	Answer Incorrect 0.00 points out of 1.00
L-T debt	Answer Incorrect 0.00 points out of 1.00
Cash from financing activites	Answer Incorrect 0.00 points out of 1.00
Change in cash	Answer Incorrect 0.00 points out of 1.00
Cash at start of year	Answer Incorrect 0.00 points out of 1.00
Cash at end of year	$Answer Incorrect 0.00 points out of 1.00